Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: like a Wolf who wrote (357)	3/1/1999 10:15:00 PM
From: out_of_the_loop	Respond to of 5582

Still here - I'm just waiting for more news. I am happy to see see there is support. I am no TA expert but I think some pros are accumulating and people who have confidence in Zicam are being patient and not selling. Personally, I think the long term potential without Zicam is decent and Zicam, if marketed well, will keep it a winner. I missed out on Allergan - I hope that GUMM behaves in a similar pattern. The shorts don't bother me. I have bought my shares and they will have to buy their shares.